Clinical Trial - Trial jRCT2071230074
Access comprehensive clinical trial information for jRCT2071230074 through Pure Global AI's free database. This phase not specified trial is sponsored by Chugai Pharmaceutical Co., Ltd. and is currently Recruiting. The study focuses on Healthy Volunteer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2071230074
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2071230074
Untitled Trial
A PHASE I, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF REVN24 IN HEALTHY MALE VOLUNTEERS
Study Focus
Interventional
Sponsor & Location
Chugai Pharmaceutical Co., Ltd.
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Healthy person accompanying sick person
Routine general health check-up of armed forces
Persons encountering health services in other circumstances
Persons encountering health services in other circumstances
Person encountering health services in unspecified circumstances
Data Source
Japan Registry Clinical Trial
jRCT2071230074
Non-Device Trial